Atypical antipsychotic adherence is associated with lower inpatient utilization and cost in bipolar I disorder.
Michael S BroderMallik GreeneEunice ChangAnn HartryTingjian YanIrina YermilovPublished in: Journal of medical economics (2018)
In the treatment of BD-I, better medication adherence to AAP was associated with fewer psychiatric hospitalizations. Among hospitalized patients, fully-adherent patients had statistically significantly lower psychiatric costs than partially-adherent ones. These findings suggest that improving adherence to AAP in BD-I may be a valuable goal from both clinical and economic perspectives.